ClinicalTrials.govpublic full text
Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics Study of Bryostatin 1 in Patients With Alzheimer's Disease
alzheimer's disease, bryostatin 1, bryostatin, safety, efficacy, pharmacokinetics, pharmacodynamics, protein kinase c, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 801886
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.